유료기사는 인쇄용 화면을 제공하지 않습니다.
Humedix to Sign an Exclusive Sales Agreement for Reedle Booster for Hospitals and Clinics
  • created on 08/11/2025 2:24:46 PM
  • modified on 08/11/2025 2:24:46 PM
[Shin-Min Joon, Edaily Reporter] Humedix of Huons Group strengthened its aesthetics portfolio by securing commercialization rights for Reedle Booster in Korea.

Humedix has signed an exclusive sales agreement for ‘Reedle Booster’ with Evov Therapeutics on August 8. From the left, Humedix CEO Kang Min-jong and Evov Therapeutics CEO Park Byung kook pose for a photo during a signing ceremony for an exclusive sales agreement. (image=Humedix)
Humedix Co. Ltd. announced on August 11 that it has signed an exclusive commercialization agreement for Reedle Booster with Evov Therapeutics Co. Ltd.

The Reedle Booster co developed by VT Cosmetics (hereafter VT) and Evov Therapeutics, is an exclusive product made for use in hospitals and clinics, leveraging the popularity of VT’s Reedle Shot in the global aesthetics market. Compared to injectable skin booster treatments, Reedle Booster procedure offers minimal pain and a shorter recovery time, allowing for a faster return to daily life after the treatment. It also provides immediate improvement in skin vitality.

With VT’s proprietary RED REEDLE™ channeling technology Reedle Booster creates micro-channels on the skin surface, facilitating delivery of active ingredients deep into the dermal layer.

Through this agreement Humedix has secured the exclusive commercialization rights in Korea for Reedle Booster EX and Reedle Booster PN, which contain next generation plant derived exosomes and small molecule polynucleotides (PN) as their respective active ingredients. Humedix plans to expand its presence in the aesthetics market by focusing on distribution to hospitals and clinics specializing in aesthetics including dermatology and plastic surgery.

Evov Therapeutics CEO Park Byung kook said “Through our partnership with Humedix which has established a strong foothold in aesthetics market in Korea Evov Therapeutics plans to promote the technological prowess of Reedle Booster and maximize its brand value.”

Humedix CEO Kang Min jong said “Reedle Booster is a professional product that started from the brand awareness and consumer needs of the Reedle Shot that has already achieved great success in K-beauty market. We have strengthened our product portfolio with new additions such as this treatment solution targeting the epidermis layer differentiated from our existing product line.”

저작권자 © 팜이데일리 - 기사 무단전재, 재배포시 법적인 처벌을 받을 수 있습니다.